(Q38107897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Aldosterone mediates cardiac fibrosis in the setting of hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

main subject

arterial hypertension

0 references

author

Jane-Lise Samuel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Feriel Azibani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Loubina Fazal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Christos Chatziantoniou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Claude Delcayre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

number of pages

6

1 reference

Current Hypertension Reports

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

395-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686824%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11906-013-0354-3

1 March 2020

exact match

0 references

cites work

Vascular remodeling in hypertension: mechanisms and treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Extrarenal effects of aldosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Mineralocorticoids, hypertension, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone, mineralocorticoid receptor, and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Myofibroblast-mediated mechanisms of pathological remodelling of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Control of BMP gene expression by long-range regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

A genetically clamped renin transgene for the induction of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Aldosterone and mineralocorticoid receptors: a personal reflection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0354-3

2-Methyl-9(alpha)-chlorocortisol, a new synthetic mineralocorticoid with unusually intense nephrotoxic actions

21 January 2018

1 reference

12 December 2020

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

12 December 2020

Mineralocorticoid excess, dietary sodium, and myocardial fibrosis

1 reference

12 December 2020

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

12 December 2020

Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension

1 reference

12 December 2020

Effects of Spironolactone Alone and in Addition to a Beta-blocker on Myocardial Histological and Electrical Remodeling in Chronic Severe Failing Rat Hearts

1 reference

12 December 2020

The mineralocorticoid receptor in heart: different effects in different cells

1 reference

12 December 2020

Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts

1 reference

12 December 2020

Cross-Talk Between Mineralocorticoid and Angiotensin II Signaling for Cardiac Remodeling

1 reference

12 December 2020

Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts

1 reference

12 December 2020

Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo

1 reference

12 December 2020

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

1 reference

12 December 2020